Dehydroepiandrosterone clinical trials
Also written DHEA and Intrarosa.
Includes 2 studies of Dehydroepiandrosterone Sulfate.
How each study uses Dehydroepiandrosterone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Dehydroepiandrosterone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 16 Nov 2016 · INTRAROSA · NDA 208470 (FDA, Drugs@FDA)
- European Union
- 8 Jan 2018 · Intrarosa · EMEA/H/C/004138 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
93 studies that test it; most in 2010 (7); 1 more planned to start later
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1995 | 3 |
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 77
EndoCeutics Inc. (9) · Cairo University (4) · National Center for Research Resources (NCRR) (4) · CHU de Quebec-Universite Laval (3) · Genelabs Technologies (3) · University of Maryland, Baltimore (2) · Kaohsiung Veterans General Hospital. (2) · ShangHai Ji Ai Genetics & IVF Institute (2)
Often tested with
Tested in the same studies.
Testosterone (3) · Pregnenolone (2) · Fluoxetine (1) · Estrogens (1) · Estradiol (1) · Coenzyme Q10 (1) · Tocotrienols (1) · BAY86-5314 (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test Dehydroepiandrosterone, phase 3 first.
- Jan 2027Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast CancerPhase 3 · European Institute of Oncology
- Dec 2026Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerPhase 2 · Ohio State University Comprehensive Cancer Center
- Jan 2027A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function DeclinePhase 1/2 · Jiangxi University of Traditional Chinese Medicine
Studies
Open first, then newest update. How each study uses Dehydroepiandrosterone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 94
- Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.RecruitingPhase 3Charite University, Berlin, GermanyNCT07843927Written as Dehydroepiandrosterone (DHEA)
- Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II TrialNot yet recruitingPhase 2VA Office of Research and DevelopmentNCT05935761Written as DHEA
- A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function DeclineRecruitingPhase 1/2Jiangxi University of Traditional Chinese MedicineNCT07535983Written as Bushen formula combined with dehydroepiandrosterone
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerRecruitingPhase 2Ohio State University Comprehensive Cancer CenterNCT07407647Written as Prasterone
- Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )Not yet recruitingPhase 2Indiana UniversityNCT07179952Written as Slow Release DHEA
- Growth Hormone and Dehydroepiandrosterone Role in Vitro FertilizationRecruitingPhase 2/3Beni-Suef UniversityNCT07323329Written as DHEA plus folic acid 400mcg per day
- Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast CancerNot yet recruitingPhase 3European Institute of OncologyNCT06611514Written as Prasterone (DHEA)
- Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)RecruitingNot applicableRoyal College of Surgeons, IrelandNCT05263557Written as Dehydroepiandrosterone (DHEA)
- Effect of DHEA on Patients With Poor Ovarian RespondsRecruitingNot applicableThe Affiliated Hospital of Inner Mongolia Medical UniversityNCT02432248Written as Dehydroepiandrosterone
- The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian RespondersNot yet recruitingPhase 2/3Beni-Suef UniversityNCT05900661Written as Dehydroepiandrosterone
- Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary SyndromeRecruitingNot applicableUniversity of BirminghamNCT05246865Written as oral androgen challenge with dehydroepiandrosterone (DHEA)
- The Effects of Fluoxetine and/or DHEACompletedEarly Phase 1University of Maryland, BaltimoreNCT03228732Written as DHEA
- Vaginal Prasterone Versus Estriol in Women With Pelvic Floor DisordersCompletedNot applicablePoznan University of Medical SciencesNCT07854873Written as Prasterone (DHEA)
- GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.CompletedPhase 4University Hospital, GhentNCT05562518Written as dehydroepiandrosterone
- Effects of DHEA in Pulmonary HypertensionCompletedPhase 2Rhode Island HospitalNCT03648385Written as DHEA tablet
- The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor RespondersTerminatedNot applicableShangHai Ji Ai Genetics & IVF InstituteNCT02357472Written as dehydroepiandrosterone
- Local DHEA and Estradiol on Dyspareunia in Postmenopausal WomenCompletedPhase 4Angelica Lindén HirschbergNCT05586711Written as vaginal DHEA 6.5 mg
- Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal WomenCompletedNot applicableUniversity of Colorado, DenverNCT05316272Written as DHEA
- Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsTerminatedPhase 2University of ArkansasNCT04493333Written as Vaginal Dehydroepiandrosterone
- A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal AtrophyCompletedPhase 3Lee's Pharmaceutical LimitedNCT04982692Written as intravaginal prasterone
See all 94 studies that test Dehydroepiandrosterone →
Given beside what is tested · 3 — Dehydroepiandrosterone is usual care or a partner of the new treatment
- Effect of Testosterone Treatment on Embryo QualityStatus unknownPhase 1/2Center for Human ReproductionNCT01662466Written as DHEA
- Adrenal and Gonadal Hormone Replacement in Anorexia NervosaCompletedPhase 2/3Boston Children's HospitalNCT00310791Written as Dehydroepiandrosterone (DHEA)
- Electroacupuncture for Diminished Ovarian ReserveCompletedPhase 1Guang'anmen Hospital of China Academy of Chinese Medical SciencesNCT02229604Written as HRT, DHEA and herb
As the comparator · 2 — what is tested is compared with Dehydroepiandrosterone
- Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to GlucocorticoidsStatus unknownPhase 1Trophea Development ABNCT03783988Written as DHEA and TRIAC
- Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian InsufficiencyCompletedPhase 1/2Guangzhou University of Traditional Chinese MedicineNCT02794948Written as dehydroepiandrosterone
Codes
What other systems call Dehydroepiandrosterone · ClinicalTrials.gg INT007306
- MeSH (NLM) D003687DehydroepiandrosteroneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 459AG36T1BPRASTERONEConfirmed FDA, NLM, Wikidata
- RxNorm 3143Confirmed FDA, Wikidata
- Wikidata Q408376dehydroepiandrosteroneConfirmed FDA, NLM, Wikidata
- DrugBank DB01708One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003687 | Dehydroepiandrosterone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 459AG36T1B | PRASTERONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3143 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408376 | dehydroepiandrosterone | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB01708 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.